Acute leukemias (both myeloid and lymphoblastic) are a group of diseases for which each
year more successful therapies are implemented. However, in a subset of cases the overall …

Abstract Purpose of Review Recent treatment advances in both acute myeloid leukemia and
acute lymphoblastic leukemia have drastically improved outcomes for these diseases, but …

Neural cell adhesion molecule 1 (NCAM1; CD56) is expressed in up to 20% of acute
myeloid leukemia (AML) patients. NCAM1 is widely used as a marker of minimal residual …

The role of the vascular microenvironment is increasingly studied in acute myeloid
leukaemia (AML). Complex interactions between endothelial cells (ECs) and pre-leukaemic …

3 Ivanova NB, Dimos JT, Schaniel C, Hackney JA, Moore KA, Lemischka IR. A stem cell
molecular signature. Science 2002; 298: 601-604. 4 Wang J, Sun Q, Morita Y, Jiang H …

The blue whale, Balaenoptera musculus, is the largest animal known to have ever existed,
making it an important case study in longevity and resistance to cancer. To further this and …

Background: Acute myeloid leukemia (AML) escape from immunosurveillance by
immunosuppression. CD200 and CD56 expression represented an independent prognostic …

Purpose Extensive studies have investigated the prognostic value of CD56 for patients with
acute myeloid leukemia (AML), but the results remained inconclusive. The aim of this meta …

Simple Summary Childhood acute myeloid leukemia (AML) remains a cancer with poor
overall outcomes. Myeloid sarcomas (MS) are extramedullary masses of leukemia cells that …

Philadelphia-negative myeloproliferative neoplasms (MPN) are clonal hematological
diseases associated with driver mutations in JAK2, CALR, and MPL genes. Moreover …